Construction of an m6A-related lncRNA model for predicting prognosis and immunotherapy in patients with lung adenocarcinoma.

Shen, Hong-Yu; Zhang, Jin; Xu, Di; Xu, Zheng; Liang, Ming-Xing; Chen, Wen-Quan; Tang, Jin-Hai; Xia, Wen-Jia

Shen, Hong-Yu; Zhang, Jin; Xu, Di; Xu, Zheng; Liang, Ming-Xing; Chen, Wen-Quan; Tang, Jin-Hai; Xia, Wen-Jia.

Afiliación

Shen HY; Department of General Surgery, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
Zhang J; Gusu School, Nanjing Medical University, Nanjing, China.
Xu D; Department of General Practice, Geriatric Hospital of Nanjing Medical University, Jiangsu Province Geriatric Hospital, Nanjing, China.
Xu Z; Department of General Surgery, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
Liang MX; Department of General Surgery, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
Chen WQ; Department of General Surgery, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
Tang JH; Department of General Surgery, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
Xia WJ; Department of General Surgery, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.

Medicine (Baltimore) ; 102(15): e33530, 2023 Apr 14.

Article en En | MEDLINE | ID: mdl-37058053

Asunto(s)

Adenocarcinoma; ARN Largo no Codificante; Humanos; ARN Largo no Codificante/genética; Inmunoterapia; Pronóstico; Pulmón

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Adenocarcinoma / ARN Largo no Codificante Tipo de estudio: Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Medicine (Baltimore) Año: 2023 Tipo del documento: Article País de afiliación: China Pais de publicación: Estados Unidos

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google